Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Chemotherapy

Carboplatin-paclitaxel effective treatment for cervical cancer

Researchers in Australia report, "One of the most active chemotherapy combinations in advanced or recurrent cervical cancer is cisplatin-paclitaxel. However, this palliative regimen is associated with significant toxicity."

"Carboplatin-paclitaxel is thus an attractive option," stated A.V. Tinker and colleagues. "Patients with advanced or recurrent carcinoma of the cervix treated with carboplatin-paclitaxel from April 2000 were included in the study. Starting doses of carboplatin-paclitaxel were: AUC 5-6 and 155-175 mg/m² respectively, repeated every 28 days. Twenty-five...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications